Literature DB >> 12118569

Effect of radiation dose rate and cyclophosphamide on pulmonary toxicity after total body irradiation in a mouse model.

A Safwat1, O S Nielsen, S El-Badawy, J Overgaard.   

Abstract

PURPOSE: Interstitial pneumonitis (IP) is still a major complication after total body irradiation (TBI) and bone marrow transplantation (BMT). It is difficult to determine the exact role of radiation in this multifactorial complication, especially because most of the experimental work on lung damage was done using localized lung irradiation and not TBI. We have thus tested the effect of radiation dose rate and combining cyclophosphamide (CTX) with single fraction TBI on lung damage in a mouse model for BMT. METHODS AND MATERIALS: TBI was given as a single fraction at a high dose rate (HDR, 0.71 Gy/min) or a low dose rate (LDR, 0.08 Gy/min). CTX (250 mg/kg) was given 24 h before TBI. Bone marrow transplantation (BMT) was performed 4-6 h after the last treatment. Lung damage was assessed using ventilation rate (VR) and lethality between 28 and 180 days (LD(50/28-180)).
RESULTS: The LD50 for lung damage, +/- standard error (SE), increased from 12.0 (+/- 0.2) Gy using single fraction HDR to 15.8 (+/- 0.6) Gy using LDR. Adding CTX shifted the dose-response curves towards lower doses. The LD50 values for the combined treatment were 53 (+/- 0.2) and 3.5 (+/- 0.2) Gy for HDR and LDR, respectively. This indicates that the combined effect of CTX and LDR was more toxic than that of combined CTX and HDR. Lung damage evaluated by VR demonstrated two waves of VR increase. The first wave of VR increase occurred after 6 weeks using TBI only and after 3 weeks in the combined CTX-TBI treatment, irrespective of total dose or dose rate. The second wave of VR elevation resembled the IP that follows localized thoracic irradiation in its time of occurrence.
CONCLUSIONS: Lung damage following TBI could be spared using LDR. However, CTX markedly enhances TBI-induced lung damage. The combination of CTX and LDR is more toxic to the lungs than combining CTX and HDR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 12118569     DOI: 10.1016/0360-3016(95)02078-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Longitudinal assessment of lung cancer progression in the mouse using in vivo micro-CT imaging.

Authors:  Eman Namati; Jacqueline Thiesse; Jessica C Sieren; Alan Ross; Eric A Hoffman; Geoffrey McLennan
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

2.  Radiation Dose-Rate Effects on Gene Expression in a Mouse Biodosimetry Model.

Authors:  Sunirmal Paul; Lubomir B Smilenov; Carl D Elliston; Sally A Amundson
Journal:  Radiat Res       Date:  2015-06-26       Impact factor: 2.841

3.  Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis.

Authors:  Natsuo Oya; Keisuke Sasai; Seiji Tachiiri; Takashi Sakamoto; Yasushi Nagata; Takashi Okada; Shinsuke Yano; Takayuki Ishikawa; Takashi Uchiyama; Masahiro Hiraoka
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

4.  Dosimetric Evaluation Between the Conventional Volumetrically Modulated Arc Therapy (VMAT) Total Body Irradiation (TBI) and the Novel Simultaneous Integrated Total Marrow Approach (SIMBa) VMAT TBI.

Authors:  Dennis Stanley; Kristen McConnell; Zohaib Iqbal; Ashlyn Everett; Jonathan Dodson; Kimberly Keene; Andrew McDonald
Journal:  Cureus       Date:  2021-06-14

5.  Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation.

Authors:  Dong-Yun Kim; Il Han Kim; Sung-Soo Yoon; Hyoung Jin Kang; Hee Young Shin; Hyun-Cheol Kang
Journal:  Radiat Oncol       Date:  2018-09-18       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.